91 research outputs found

    Mean FECs (expressed as EPGs) in different stool pieces along the length axis of whole-stool samples, among 59 helminth-positive participants from Azaguié, Côte d'Ivoire, in 2010.

    No full text
    <p>Mean FECs (expressed as EPGs) in different stool pieces along the length axis of whole-stool samples, among 59 helminth-positive participants from Azaguié, Côte d'Ivoire, in 2010.</p

    Mean eggs per gram (EPG) values in surface and center of stool samples, among 102 helminth-positive participants from Azaguié Côte d'Ivoire, in 2010.

    No full text
    <p>Mean eggs per gram (EPG) values in surface and center of stool samples, among 102 helminth-positive participants from Azaguié Côte d'Ivoire, in 2010.</p

    Adverse events 4 and 24 hours after administration of crushed praziquantel tablets (<i>n</i> = 234).

    No full text
    <p>The study was carried out in two villages in Azaguié, south Côte d'Ivoire between June and November 2011, focusing on preschool-aged children.</p

    <i>S. mansoni</i> and <i>S. haematobium</i> cure and egg reduction rates, as assessed 3 weeks after praziquantel treatment, stratified by diagnostic approach.

    No full text
    <p>The study was carried out in two villages in Azaguié, south Côte d'Ivoire, between June and November 2011, focusing on preschool-aged children.</p><p>CI, confidence interval; CR, cure rate; EPG, eggs/gram of stool; ERR, egg reduction rate; NA, not applicable; POC-CCA, point-of-care circulating cathodic antigen.</p

    Baseline prevalence of <i>S. mansoni</i> and <i>S. haematobium</i>, stratified by sex and diagnostic approach.

    No full text
    <p>The study was carried out in two villages in Azaguié, south Côte d'Ivoire, between June and November 2011. All preschool-aged children who had at least one stool sample examined with duplicate Kato-Katz thick smears and one urine sample subjected to a filtration method before and 3 weeks after praziquantel administration were included (per-protocol analysis).</p><p>POC-CCA, point-of-care circulating cathodic antigen.</p

    Flow chart and study adherence.

    No full text
    <p>The study was carried out in the villages of Azaguié Makouguié and Azaguié M'Bromé in south Côte d'Ivoire, between June and November 2011.</p
    corecore